What's new

Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 17, Status: Authorised

May 6, 2025 - 10:29
 0
Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 17, Status: Authorised
Read More

Tags:

Previous Article

City West Country moves BYD to larger Exeter showroom

Next Article

Product Management Services (PMS) - Implementation of International Organization...

Related Posts

Vaccine-preventable diseases: key facts

Vaccine-preventable diseases: key facts

Apr 28, 2025  0

Veterinary medicines European public assessment report (EPAR): Pirsue, pirlimycin, Date of authorisation: 29/01/2001, Status: Withdrawn

Veterinary medicines European public assessment report ...

May 2, 2025  0

Human medicines European public assessment report (EPAR): Dazluma, troriluzole, Status: Application withdrawn

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0